Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study aims to create a universal score for assistive tech performance

NCT ID NCT07407725

Knowledge-focused Sponsor: Shirley Ryan AbilityLab Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is developing a standard test to measure how well assistive technologies (like eye trackers) and brain-computer interfaces help people with spinal cord injury or ALS use computers and phones. Researchers will test 60 participants, including healthy volunteers and people with these conditions, using a custom digital assessment interface. The goal is to create a reliable index that combines performance, clinician, and patient reports to compare different devices.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Eye tracker (Tobii Dynavox PCEye 5)
What this could lead to
If successful, this could create a standard tool to compare different assistive technologies, helping doctors and researchers choose the best device for each person.
What could go wrong
This is an early-stage study focused on developing a measurement tool, not testing a treatment. It may not lead to any direct improvement in patient care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Enrollment will involve three different cohorts, namely a cohort of healthy participant, a cohort of ALS/SCI participant who underwent the implant of an invasive BCI device, and a cohort of ALS/SCI participants without any implanted BCI device. Below are listed the inclusion and exclusion criteria for each diagnostic group. Spinal Cord Injury (SCI): Inclusion Criteria: * Age at or above 18 years old; * Diagnosis of spinal cord injury, at the level of T1 or above levels (between C1 and T1); * Ability to communicate independently or with a support device, or with a legal representative; * Ability to participate in a study session for about 3 hours (e.g., endurance, fatigue), which may include breaks as needed. Exclusion Criteria: * Participation in another trial that would conflict with the current study or clinical endpoint interference may occur. Amyotrophic Lateral Sclerosis (ALS): Inclusion criteria: * Age at or above 18 years old; * Diagnosis of amyotrophic lateral sclerosis; * Ability to communicate independently, with a support device, or with a legal representative; * Ability to participate in a study session for about 3 hours (e.g., endurance, fatigue), which may include breaks as needed. Exclusion criteria: ● Participation in another trial that would conflict with the current study or clinical endpoint interference may occur. Healthy Controls: Inclusion criteria: * Age at or above 18 years old; * No history of neurological or psychiatric disorders; * Ability to provide written informed consent; * Ability to participate in a study session for about 3 hours (e.g., endurance, fatigue), which may include breaks as needed. Exclusion criteria: * Participation in another trial that would conflict with the current study or clinical endpoint interference may occur; * Cognitive, visual, or auditory deficits that would interfere with study participation; * Current or prior diagnosis or condition that could confound study assessments.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALS (amyotrophic lateral sclerosis) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

amyotrophic lateral sclerosis spinal cord injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALS (amyotrophic lateral sclerosis) Spinal cord injury

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Shirley Ryan AbilityLab

    RECRUITING

    Chicago, Illinois, 60611, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.